Crossmark

Loss of NFBD1/MDC1 disrupts homologous recombination repair and sensitizes nasopharyngeal carcinoma cells to PARP inhibitors

Crossref DOI link: https://doi.org/10.1186/s12929-019-0507-z

Published Online: 2019-02-04

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Zhihai

Zuo, Wenqi

Zeng, Quan

Qian, Yi

Li, Yanshi

Liu, Chuan

Wang, Jue

Zhong, Shixun

Bu, Youquan

Hu, Guohua https://orcid.org/0000-0002-6220-2084
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81470676 and 81271061)

Nurture Fund of The First Affiliated Hospital of Chongqing Medical University (2018PYJJ-01)
License Information

Text and Data Mining valid from 2019-02-04
More Information

Article History

Received: 20 August 2018

Accepted: 22 January 2019

First Online: 4 February 2019

Ethics approval and consent to participate

: All procedures followed were in accordance with the ethical standards of the responsible committee on animal experimentation and with the Helsinki Declaration of 1975 and later versions. All animal husbandry and experiments were performed under a protocol approved by Institutional Animal Care Committee at Chongqing Medical University.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.